Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Stephen J Nicholls, Kiyoko Uno & Yu Kataoka. (2011) Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk. Expert Review of Cardiovascular Therapy 9:11, pages 1383-1390.
Read now
Read now
Sydney B Long, Michael J Blaha, Roger S Blumenthal & Erin D Michos. (2011) Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. Clinical Interventions in Aging 6, pages 27-35.
Read now
Read now
Richard Kones. (2010) Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective. Drug Design, Development and Therapy 4, pages 383-413.
Read now
Read now
Venkata Narla, Michael J Blaha, Roger S Blumenthal & Erin D Michos. (2009) The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences. Vascular Health and Risk Management 5, pages 1033-1042.
Read now
Read now
Stephen J Nicholls. (2008) Rosuvastatin and progression of atherosclerosis. Expert Review of Cardiovascular Therapy 6:7, pages 925-933.
Read now
Read now
MT Bennett, KW Johns & GP Bondy. (2008) Current and future treatments of HIV-associated dyslipidemia. Future Lipidology 3:2, pages 175-188.
Read now
Read now
Articles from other publishers (16)
Tak Kyu Oh & In‐Ae Song. (2020) Prior statin therapy and 30‐day mortality in South Korean patients with acute respiratory distress syndrome. Acta Anaesthesiologica Scandinavica 65:2, pages 236-243.
Crossref
Crossref
Ibrahim Elsayed, Rania Moataz El-Dahmy, Soad Z. El-Emam, Ahmed Hassen Elshafeey, Nabaweya Abdelaziz Abd El Gawad & Omaima Naim El-Gazayerly. (2020) Response surface optimization of biocompatible elastic nanovesicles loaded with rosuvastatin calcium: enhanced bioavailability and anticancer efficacy. Drug Delivery and Translational Research 10:5, pages 1459-1475.
Crossref
Crossref
I. A. Alekseeva, T. E. Kolmakova & M. B. Ezhov. (2019) Fixeddose combination of rosuvastatin + ezetimibe: ease of use, safety and efficacy. Medical Council:16, pages 21-26.
Crossref
Crossref
Tak Kyu Oh, In-Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, You Hwan Jo & Hee-Jung Jee. (2019) Preadmission Statin Use and 90-day Mortality in the Critically Ill. Anesthesiology 131:2, pages 315-327.
Crossref
Crossref
Eleni Pappa, Christos V. Rizos, Theodosios D. Filippatos & Moses S. Elisaf. (2019) Emerging Fixed-Dose Combination Treatments for Hyperlipidemia. Journal of Cardiovascular Pharmacology and Therapeutics 24:4, pages 315-322.
Crossref
Crossref
Qixiao Jiang, Ranran Hao, Wencheng Wang, Hui Gao & Chunbo Wang. (2016) SIRT1/Atg5/autophagy are involved in the antiatherosclerosis effects of ursolic acid. Molecular and Cellular Biochemistry 420:1-2, pages 171-184.
Crossref
Crossref
Cansel Kose Ozkan, Sevinc Kurbanoglu, Ozgur Esim, Ayhan Savaser, Sibel A. Ozkan & Yalcin Ozkan. (2016) Simultaneous Determination and Drug Dissolution Testing of Combined Amlodipine Tablet Formulations Using RP-LC. Chromatographia 79:17-18, pages 1143-1151.
Crossref
Crossref
Tzu-Tang Wei, Yi-Ting Lin, Ruo-Yu Tseng, Chia-Tung Shun, Yu-Chin Lin, Ming-Shiang Wu, Jim-Min Fang & Ching-Chow Chen. (2016) Prevention of Colitis and Colitis-Associated Colorectal Cancer by a Novel Polypharmacological Histone Deacetylase Inhibitor. Clinical Cancer Research 22:16, pages 4158-4169.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
285
315
.
Joseph M. Custodio, Hui Wang, Jia Hao, Eve-Irene Lepist, Adrian S. Ray, Jessica Andrews, Kah Hiing J. Ling, Andrew Cheng, Brian P Kearney & Srinivasan Ramanathan. (2014) Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin. The Journal of Clinical Pharmacology 54:6, pages 649-656.
Crossref
Crossref
Kosmas I. Paraskevas & Dimitri P. Mikhailidis. (2011) Carotid Artery Stenosis and Heart Valve Surgery: A Complex Scenario. Angiology 62:8, pages 597-600.
Crossref
Crossref
Tatjána Ábel & János Fehér†. (2010) Role of rosuvastatin in lipid-lowering therapy today. Orvosi Hetilap 151:35, pages 1424-1428.
Crossref
Crossref
Masahiko Kurabayashi, Tsutomu Yamazaki & SUBARU Study Group. (2008) Superior Benefit of Aggressive Lipid-Lowering Therapy for High- Risk Patients Using Statins: the SUBARU Study -More Hypercholesterolemic Patients Achieve Japan Atherosclerosis Society LDL-C Goals with Rosuvastatin Therapy than with Atorvastatin Therapy. Journal of Atherosclerosis and Thrombosis 15:6, pages 314-323.
Crossref
Crossref
Fabio Mazza, Claudia Stefanutti, Serafina Di Giacomo, Antonio Vivenzio, Nadia Fraone, Bruno Mazzarella & Antonello Bucci. (2008) Effects of Low-Dose Atorvastatin and Rosuvastatin on Plasma Lipid Profiles. American Journal of Cardiovascular Drugs 8:4, pages 265-270.
Crossref
Crossref
Jisun Oh & Robert A Hegele. (2007) HIV-associated dyslipidaemia: pathogenesis and treatment. The Lancet Infectious Diseases 7:12, pages 787-796.
Crossref
Crossref
Yunxia Li, Xuehua Jiang, Ke Lan, Ruoqi Zhang, Xue Li & Qian Jiang. (2007) Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study. Clinical Therapeutics 29:10, pages 2194-2203.
Crossref
Crossref